第 1 到 39 筆結果,共 39 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 31 | 29 | |
2 | 2018 | Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment | Chang M.-C.; YU-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; Hsieh S.-F.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Molecular Therapy | 31 | 28 | |
3 | 2017 | Metronomic chemotherapy and immunotherapy in cancer treatment | YU-LI CHEN ; Chang M.-C.; WEN-FANG CHENG | Cancer Letters | 118 | 111 | |
4 | 2016 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; YA-JUNG CHENG ; Jen Y.-W.; CHI-AN CHEN ; WEN-FANG CHENG ; WEI-ZEN SUN | American Journal of Cancer Research | 9 | ||
5 | 2016 | Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; Chen T.-C.; Tang Y.-C.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Gene Therapy | 16 | 16 | |
6 | 2015 | IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients | YU-LI CHEN ; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 11 | 8 | |
7 | 2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 8 | ||
8 | 2015 | Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation | Huang C.-T.; Chang M.-C.; YU-LI CHEN ; Chen T.-C.; CHI-AN CHEN ; WEN-FANG CHENG | Cancer Letters | 36 | 34 | |
9 | 2015 | Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma | YING-CHENG CHIANG ; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; CHI-AN CHEN ; WEN-FANG CHENG | Oncotarget | 26 | 26 | |
10 | 2015 | Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients | Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; KUAN-TING KUO ; CHI-AN CHEN ; WEN-FANG CHENG | Scientific Reports | 13 | 10 | |
11 | 2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
12 | 2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
13 | 2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
14 | 2013 | Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma | YU-LI CHEN ; WEN-FANG CHENG ; Chang M.-C.; Lin H.-W.; Huang C.-T.; CHUNG-LIANG CHIEN ; CHI-AN CHEN | Gynecologic Oncology | 20 | 16 | |
15 | 2013 | Fusion Protein Vaccines Targeting Two Tumor Antigens Generate Synergistic Anti-Tumor Effects | WEN-FANG CHENG ; Chang M.-C.; WEI-ZEN SUN ; Jen Y.-W.; Liao C.-W.; Chen Y.-Y.; CHI-AN CHEN | PLoS ONE | 5 | 5 | |
16 | 2012 | Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response | YU-LI CHEN ; Chang M.-C.; Huang C.-Y.; YING-CHENG CHIANG ; Lin H.-W.; CHI-AN CHEN ; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Oncology | 107 | 103 | |
17 | 2012 | Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways | Chang M.-C.; CHI-AN CHEN ; Chen P.-J.; YING-CHENG CHIANG ; YU-LI CHEN ; TSUI-LIEN MAO ; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG | Biochemical Journal | 113 | 112 | |
18 | 2012 | New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation | Chang M.-C.; YING-CHENG CHIANG ; Ho C.-M.; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG ; Chou C.-Y. | Taiwanese Journal of Obstetrics and Gynecology | 5 | 4 | |
19 | 2012 | Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects | Chang M.-C.; CHIEN-NAN LEE ; YU-LI CHEN ; YING-CHENG CHIANG ; WEI-ZEN SUN ; Hu Y.-H.; CHI-AN CHEN ; WEN-FANG CHENG | Clinical Science | 11 | 11 | |
20 | 2012 | Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses | YU-LI CHEN ; Chang M.-C.; CHI-AN CHEN ; Lin H.-W.; WEN-FANG CHENG ; CHUNG-LIANG CHIEN | PLoS ONE | 34 | 29 | |
21 | 2011 | Influence of morphine on host immunity | Chang M.-C.; SHOU-ZEN FAN ; PO-NI HSIAO ; WEN-FANG CHENG ; WEI-ZEN SUN | Acta Anaesthesiologica Taiwanica | 11 | 0 | |
22 | 2010 | Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis | CHI-AN CHEN ; Ho C.-M.; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; Syu M.-H.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Therapy | 82 | 72 | |
23 | 2010 | Morphine-sparing effect by cox-1 inhibitor sustains analgesic function without compromising antigen-specific immunity and anti-tumor effect of naked DNA vaccine | WEI-ZEN SUN ; Chang M.-C.; PO-NI HSIAO ; CHI-AN CHEN ; Hsu Y.-T.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Immunopathology and Pharmacology | 11 | 9 | |
24 | 2009 | Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway | Chang M.-C.; CHI-AN CHEN ; CHANG-YAO HSIEH ; CHIEN-NAN LEE ; Su Y.-N.; Hu Y.-H.; WEN-FANG CHENG | Biochemical Journal | 57 | 55 | |
25 | 2009 | Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects | CHI-AN CHEN ; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; CHANG-YAO HSIEH ; Chen S.M.; PO-NI HSIAO ; WEN-FANG CHENG | Gene Therapy | 15 | 13 | |
26 | 2009 | Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways | PO-NI HSIAO ; Chang M.-C.; WEN-FANG CHENG ; CHI-AN CHEN ; Lin H.-W.; CHANG-YAO HSIEH ; WEI-ZEN SUN | Toxicology | 74 | 70 | |
27 | 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
28 | 2008 | Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism | WEN-FANG CHENG ; Chang M.-C.; WEI-ZEN SUN ; CHIEN-NAN LEE ; Lin H.-W.; Su Y.-N.; CHANG-YAO HSIEH ; CHI-AN CHEN | Gene Therapy | 26 | 25 | |
29 | 2007 | IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways | CHANG-YAO HSIEH ; CHI-AN CHEN ; Huang C.-Y.; Chang M.-C.; CHIEN-NAN LEE ; Su Y.-N.; WEN-FANG CHENG | Molecular Therapy | 22 | 20 | |
30 | 2007 | DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens | Huang C.-Y.; CHI-AN CHEN ; CHIEN-NAN LEE ; Chang M.-C.; Su Y.-N.; Lin Y.-C.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Gynecologic Oncology | 32 | 23 | |
31 | 2006 | Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis | WEN-FANG CHENG ; LI-KUEI CHEN ; CHI-AN CHEN ; Chang M.-C.; PO-NI HSIAO ; Su Y.-N.; CHIEN-NAN LEE ; Jeng H.-J.; CHANG-YAO HSIEH ; WEI-ZEN SUN | Molecular Therapy | 22 | 18 | |
32 | 2006 | Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity | WEN-FANG CHENG ; CHIEN-NAN LEE ; Su Y.-N.; Chai C.-Y.; Chang M.-C.; Polo J.M.; Hung C.-F.; Wu T.-C.; CHANG-YAO HSIEH ; CHI-AN CHEN | Cancer Gene Therapy | 22 | 13 | |
33 | 2005 | Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: A highly efficient and reliable carrier-screening test | Su Y.-N.; Hung C.-C.; Li H.; CHIEN-NAN LEE ; WEN-FANG CHENG ; PO-NIEN TSAO ; Chang M.-C.; CHIA-LI YU ; Hsieh W.-S.; Lin, Win-Li ; Hsu S.-M. | Human Mutation | 64 | 57 | |
34 | 2005 | Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects | Liao C.-W.; CHI-AN CHEN ; CHIEN-NAN LEE ; Su Y.-N.; Chang M.-C.; Syu M.-H.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Cancer Research | 45 | 41 | |
35 | 2005 | Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations | WEN-FANG CHENG ; CHIEN-NAN LEE ; Su Y.-N.; Chang M.-C.; Hsiao W.-C.; CHI-AN CHEN ; CHANG-YAO HSIEH | Immunology | 14 | 13 | |
36 | 2005 | Hypoxia-induced apoptosis in endothelial cells and embryonic stem cells | CHIEN-NAN LEE ; WEN-FANG CHENG ; Chang M.-C.; Su Y.-N.; CHI-AN CHEN ; FON-JOU HSIEH | Apoptosis | 37 | 36 | |
37 | 2005 | Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway | WEN-FANG CHENG ; CHIEN-NAN LEE ; Chang M.-C.; Su Y.-N.; CHI-AN CHEN ; CHANG-YAO HSIEH | Molecular Therapy | 15 | 14 | |
38 | 2004 | Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways | WEN-FANG CHENG ; Hung C.-F.; CHIEN-NAN LEE ; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; CHI-AN CHEN ; CHANG-YAO HSIEH | European Journal of Immunology | 15 | 14 | |
39 | 2001 | The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway | LING-HUNG WEI ; Kuo M.-L.; CHI-AN CHEN ; Chou C.-H.; WEN-FANG CHENG ; Chang M.-C.; Su J.-L.; CHANG-YAO HSIEH | Oncogene | 156 | 145 |